Noninvasix
PrivateLast Round
Reverse Merger
Dec 16, 2025
Total Funding Raised
$3.43M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Noninvasix is a medical device company developing a non-invasive patient monitoring system using patented optoacoustic technology to measure organ oxygenation, with initial applications in neonatal care and sepsis.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Noninvasix Comparables
Compare Noninvasix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GE HealthCare Technologies Inc. | 74% | |
| Medtronic | 72% | |
| Baxter International Inc | 71% |
Noninvasix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Reverse Merger | Dec 16, 2025 | ||||
| Private Placement | Oct 30, 2025 | ||||
| Seed | Feb 4, 2021 | ||||
| Seed | Jan 7, 2019 |
Key People
Founding team and executive leadership
Noninvasix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Philips Ventures | Seed, Accelerator |
| Athenian Capital | Seed |
| NIH RADx | Grant |
| The Catalyst Fund | Seed |
| Texas Medical Center Venture Fund | Seed |
| Cypher Metaverse Inc. | Reverse Merger |
| Green Park & Golf Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2025
$3M raised from Cypher Metaverse Inc.
- Oct 30, 2025
$3M raised in a private placement round.
Noninvasix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Noninvasix's valuation, stock price, and market status.
Is Noninvasix a public or private company?
Noninvasix is a private company.
What is the current stock price of Noninvasix?
Noninvasix is a private company, so its shares have no public market price. Caplight tracks Noninvasix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Noninvasix worth (valuation)?
Valuation information for Noninvasix is not publicly available.
Can I buy Noninvasix stock?
Noninvasix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Noninvasix's last funding round?
Noninvasix's most recent funding round was Reverse Merger on December 16, 2025.
Who are the main investors in Noninvasix?
Key investors in Noninvasix include Texas Medical Center Venture Fund.
Will Noninvasix IPO soon?
No public IPO plans have been announced for Noninvasix.
How can I track Noninvasix secondary market activity?
Caplight tracks bids, offers, and trades in Noninvasix's shares on secondary markets.